Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZG-802 Phase IIa Trial in Underactive Bladder
jRCT2071230011Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acotiamide in Detrusor hypocontractility (3 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Started Jul 2023; status: completed.
02
Drugs
acotiamide
03
Conditions
Detrusor hypocontractility
Beyond the preview
Go deeper on jRCT2071230011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230011.